Lava Therapeutics shares delisted from Nasdaq following completion of acquisition By Investing.com
Lava Therapeutics shares delisted from Nasdaq following completion of acquisition
Was macht LAVA Therapeutics?
Unternehmensprofil
LAVA Therapeutics NV is an immuno-oncology company, which engages in the proprietary Gammabody platform to develop a portfolio of bispecific gamma delta T cell engagers for the potential treatment of solid tumors and hematological malignancies. The company was founded by Erik van den Berg in 2016 and is headquartered in Utrecht, the Netherlands.
Chart der LAVA Therapeutics Aktie
Charttool öffnen
Aktuelle Nachrichten zu LAVA Therapeutics
Weitere Nachrichten
Das berichten andere über LAVA Therapeutics
XOMA Royalty Extends Tender Offer to Acquire LAVA Therapeutics N.V.
XOMA Royalty extends its tender offer for LAVA Therapeutics.
LAVA Therapeutics stock rises on acquisition deal with XOMA Royalty By Investing.com
LAVA Therapeutics stock rises on acquisition deal with XOMA Royalty
XOMA Royalty to acquire HilleVax and LAVA Therapeutics in separate deals By Investing.com
XOMA Royalty to acquire HilleVax and LAVA Therapeutics in separate deals
Wir finden für unsere Leser softwaregestützt die besten Aktien der Welt
und schreiben darüber, wie man diese handeln muss, um Geld zu verdienen.